547 related articles for article (PubMed ID: 16537617)
21. Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant.
Schneidawind D; Schmitt A; Wiesneth M; Mertens T; Bunjes D; Freund M; Schmitt M
Leuk Lymphoma; 2010 Jun; 51(6):1055-62. PubMed ID: 20370539
[TBL] [Abstract][Full Text] [Related]
22. Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.
Mani J; Wang L; Hückelhoven AG; Schmitt A; Gedvilaite A; Jin N; Kleist C; Ho AD; Schmitt M
Oncotarget; 2017 Jan; 8(2):2485-2500. PubMed ID: 27705933
[TBL] [Abstract][Full Text] [Related]
23. Early BK polyomavirus (BKV) reactivation in donor kidney is a risk factor for development of BKV-associated nephropathy.
Saundh BK; Baker R; Harris M; Welberry Smith MP; Cherukuri A; Hale A
J Infect Dis; 2013 Jan; 207(1):137-41. PubMed ID: 23100561
[TBL] [Abstract][Full Text] [Related]
24. Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients.
Bodaghi S; Comoli P; Bösch R; Azzi A; Gosert R; Leuenberger D; Ginevri F; Hirsch HH
J Clin Microbiol; 2009 Aug; 47(8):2577-85. PubMed ID: 19474265
[TBL] [Abstract][Full Text] [Related]
25. BK-VP3 as a new target of cellular immunity in BK virus infection.
Mueller K; Schachtner T; Sattler A; Meier S; Friedrich P; Trydzenskaya H; Hinrichs C; Trappe R; Thiel A; Reinke P; Babel N
Transplantation; 2011 Jan; 91(1):100-7. PubMed ID: 21452414
[TBL] [Abstract][Full Text] [Related]
26. BK virus genotypes and humoral response in kidney transplant recipients with BKV associated nephropathy.
Gras J; Nere ML; Peraldi MN; Bonnet-Madin L; Salmona M; Taupin JL; Desgrandchamps F; Verine J; Brochot E; Amara A; Molina JM; Delaugerre C
Transpl Infect Dis; 2023 Apr; 25(2):e14012. PubMed ID: 36748721
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.
Hirsch HH; Knowles W; Dickenmann M; Passweg J; Klimkait T; Mihatsch MJ; Steiger J
N Engl J Med; 2002 Aug; 347(7):488-96. PubMed ID: 12181403
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic T lymphocyte recognition sequences as markers for distinguishing among tumour antigens encoded by SV40, BKV and JCV.
Tevethia SS; Mylin L; Newmaster R; Epler M; Lednicky JA; Butel JS; Tevethia MJ
Dev Biol Stand; 1998; 94():329-39. PubMed ID: 9776254
[TBL] [Abstract][Full Text] [Related]
29. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus.
Hamilton RS; Gravell M; Major EO
J Clin Microbiol; 2000 Jan; 38(1):105-9. PubMed ID: 10618072
[TBL] [Abstract][Full Text] [Related]
30. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience.
Hassan S; Mittal C; Amer S; Khalid F; Patel A; Delbusto R; Samuel L; Alangaden G; Ramesh M
Transpl Infect Dis; 2014 Feb; 16(1):55-60. PubMed ID: 24283677
[TBL] [Abstract][Full Text] [Related]
31. Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.
Solis M; Velay A; Porcher R; Domingo-Calap P; Soulier E; Joly M; Meddeb M; Kack-Kack W; Moulin B; Bahram S; Stoll-Keller F; Barth H; Caillard S; Fafi-Kremer S
J Am Soc Nephrol; 2018 Jan; 29(1):326-334. PubMed ID: 29042457
[TBL] [Abstract][Full Text] [Related]
32. Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach.
Blazquez-Navarro A; Schachtner T; Stervbo U; Sefrin A; Stein M; Westhoff TH; Reinke P; Klipp E; Babel N; Neumann AU; Or-Guil M
PLoS Comput Biol; 2018 May; 14(5):e1005998. PubMed ID: 29746472
[TBL] [Abstract][Full Text] [Related]
33. BK virus-associated infection in cerebrospinal fluid of neurological patients and mutation analysis of the complete VP1 gene in different patient groups.
Bárcena-Panero A; Van Ghelue M; Khan MT; Echevarría JE; Fedele G; Moens U
J Cell Physiol; 2012 Jan; 227(1):136-45. PubMed ID: 21374594
[TBL] [Abstract][Full Text] [Related]
34. BK virus infection in transplant recipients: clinical manifestations, treatment options and the immune response.
van Aalderen MC; Heutinck KM; Huisman C; ten Berge IJ
Neth J Med; 2012 May; 70(4):172-83. PubMed ID: 22641625
[TBL] [Abstract][Full Text] [Related]
35. Cellular immune responses to BK virus.
Comoli P; Hirsch HH; Ginevri F
Curr Opin Organ Transplant; 2008 Dec; 13(6):569-74. PubMed ID: 19060544
[TBL] [Abstract][Full Text] [Related]
36. Different patterns of BK and JC polyomavirus reactivation following renal transplantation.
Saundh BK; Tibble S; Baker R; Sasnauskas K; Harris M; Hale A
J Clin Pathol; 2010 Aug; 63(8):714-8. PubMed ID: 20702473
[TBL] [Abstract][Full Text] [Related]
37. Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation.
Chakera A; Bennett S; Lawrence S; Morteau O; Mason PD; O'Callaghan CA; Cornall RJ
Clin Exp Immunol; 2011 Sep; 165(3):401-9. PubMed ID: 21671906
[TBL] [Abstract][Full Text] [Related]
38. Donor origin of BKV replication after kidney transplantation.
Schmitt C; Raggub L; Linnenweber-Held S; Adams O; Schwarz A; Heim A
J Clin Virol; 2014 Feb; 59(2):120-5. PubMed ID: 24361208
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the BC-loop of the BKV VP1 region do not influence viral load in renal transplant patients.
Krautkrämer E; Klein TM; Sommerer C; Schnitzler P; Zeier M
J Med Virol; 2009 Jan; 81(1):75-81. PubMed ID: 19031459
[TBL] [Abstract][Full Text] [Related]
40. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
Schwarz A; Linnenweber-Held S; Heim A; Framke T; Haller H; Schmitt C
Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
